Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2022
Headcount
5
HQ
Ramat Hasharon, Israel
Sector
Health Tech & Life Sciences
About
RECMA Bio was established to resolve one of the most challenging unmet needs in medicine, tissue regeneration.
RECMA Bio is combining biomaterial sciences, tissue engineering, 3D bioprinting, and robotics, to develop a robotic system for in-situ bioprinting, harnessing the body's natural abilities to regenerate and heal.
Q&A
- What is RECMA Bio's primary focus?
- RECMA Bio is focused on resolving unmet needs in tissue regeneration by combining biomaterial sciences, tissue engineering, 3D bioprinting, and robotics to develop a robotic system for in-situ bioprinting.
- When was RECMA Bio founded?
- RECMA Bio was founded in October 2022.
- What is the current status of RECMA Bio?
- RECMA Bio is currently inactive, having ceased operations in October 2024.
- Where is RECMA Bio headquartered?
- RECMA Bio is headquartered in Ramat Hasharon, Israel.
- What sector does RECMA Bio primarily operate in?
- RECMA Bio primarily operates in the Health Tech & Life Sciences sector.
- What technologies does RECMA Bio utilize?
- RECMA Bio utilizes Machinery & Robotics and 3D Printing & Additive Manufacturing technologies.
- Who is the CEO of RECMA Bio?
- Chen Levin is the CEO of RECMA Bio.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Machinery & Robotics3D Printing & Additive Manufacturing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
biomed3d-technologybiomaterialsbioconvergencemedical-devicesroboticstissue-regeneration
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/90819553 |
Identifiers & details
| Founded | 2022-10 |
|---|---|
| Employees (exact) | 5 |
| Status reason | Non Active, Oct 2024 ceased to operate |